Integra LifeSciences Corporation clinical trials
Integra LifeSciences Corporation is the lead sponsor of 5 current clinical trials in our USA, China, Germany, Spain, Belgium and Switzerland registers. 3 are recruiting patients now. The most common phase is Observational. The most-studied condition is Hydrocephalus.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Integra LifeSciences Corporation
5 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Bactiseal Catheter Safety Registry Study
NCT06276543 · ClinicalTrials.gov ↗ · Hydrocephalus
|
Observational | Recruiting | 2024-09 | China |
|
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
NCT04494295 · Supratentorial Hemorrhage
|
Observational | Recruiting | 2020-10 | USA |
|
AERA Pediatrics Registry
NCT07071298 · Dysfunction of Eustachian Tube
|
Observational | Recruiting | 2025-06 | USA |
|
A Modified Platform Trial of Multiple CAMPs for the Management of Diabetic Foot Ulcers and Venous Leg Ulcers
NCT06453187 · Diabetic Foot Ulcer, Venous Leg Ulcer
|
Not applicable | By invitation | 2024-11 | USA |
|
Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve
NCT05397106 · ClinicalTrials.gov ↗ · Hydrocephalus, Hydrocephalus in Children, NPH (Normal Pressure Hydrocephalus)
|
Observational | Active, closed | 2023-01 | Germany, Spain, Belgium, Switzerland |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in Integra LifeSciences Corporation trials
8 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in USA | 3 | 2 |
| Clinical trials in China | 1 | 1 |
| Clinical trials in Germany | 1 | 0 |
| Clinical trials in Spain | 1 | 0 |
| Clinical trials in Belgium | 1 | 0 |
| Clinical trials in Switzerland | 1 | 0 |
A trial with sites in more than one country appears in each of those registers.
Other sponsors in Hydrocephalus
| Sponsor | Trials |
|---|---|
| Rhaeos | 9 |
| Boston Children's Hospital | 2 |
Sponsors with the most current trials registered for this condition.
Questions about Integra LifeSciences Corporation trials
How many clinical trials does Integra LifeSciences Corporation sponsor?
Integra LifeSciences Corporation is the lead sponsor of 5 current trials on ClinicalTrials.gov in our USA, China, Germany, Spain, Belgium and Switzerland registers, as of the registry sync on 11 November 2026. Completed and withdrawn studies are not counted.
Are Integra LifeSciences Corporation trials recruiting?
Yes. 3 of its 5 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 11 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.